Ya‐Mei Hu

Guangzhou University of Chinese Medicine

Also affiliated with Tongji Hospital, Huazhong University of Science and Technology

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer”.

Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer

Cancer Discovery(2024)10.1158/2159-8290.cd-24-0559

N/A

0DataRank · unranked

46 citations

Fanny Polesso, Julie N. Graff, Jessica E. Hawley, Alexis K. Smith, Arian Lundberg +35 more

PROX1 is an early driver of lineage plasticity in prostate cancer

Journal of Clinical Investigation(2025)10.1172/jci187490

N/A

0DataRank · unranked

9 citations

Mingchen Shi, Anbarasu Kumaraswamy, Dong Lin, Dhruv Khokhani, Yong Wang +41 more

Elevated Tumor-Associated Androgen Receptor Activity Correlates with Poor Immune Infiltration and Immunotherapy Response across Cancer Types

Cancer Research Communications(2025)10.1158/2767-9764.crc-25-0409

N/A

0DataRank · unranked

2 citations

Faming Zhao, Julie N. Graff, Canping Chen, Yi Zhang, Jayne M. Stommel +11 more

Transcriptional profiling clarifies a program of enzalutamide extreme non-response in lethal prostate cancer

npj Precision Oncology(2025)10.1038/s41698-025-01002-8

N/A

0DataRank · unranked

1 citations

Ya‐Mei Hu, Joel A. Yates, Chao Zhang, Eva S. Rodansky, Dhruv Khokhani +26 more